Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Technology Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 74,348 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 1,340 · Balance 71,975 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,668 · Balance 73,643 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 3,324 · Balance 76,967 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,701 · Balance 78,668 Row 5 · 2026-10-01 · Tax withholding · Disposed 4,320 · Balance 74,348 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 1,340 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,668 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 13,296 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 3,324 · Balance 13,296 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 10,202 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,701 · Balance 10,202 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2025 Filed Dec 11, 2025 02:31 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCommon Stock | 68,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000008 · wk-form4_1765420294.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Chudova Family Trust Disclosed balance after: 68,144 Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:31 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCommon Stock | 68,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000008 · wk-form4_1765420294.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,734 F1 · shares: Reflects changes in form of ownership from direct to indirect due to transfer of shares to The Chudova Family Trust. Read SEC document |
| December 08, 2025 Filed Jan 22, 2026 22:42 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCommon Stock | 44,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000004 · wk-form5_1769121738.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,370 F1 · shares: Reflects changes in form of ownership from direct to indirect due to transfer of shares to The Chudova Family Trust. Incorrect number of shares reported back on Form 4 dated 12/8/2025, filed 12/10/2025. Read SEC document |
| December 08, 2025 Filed Jan 22, 2026 22:42 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCommon Stock | 44,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000004 · wk-form5_1769121738.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Chudova Family Trust Disclosed balance after: 9,538 F1 · shares: Reflects changes in form of ownership from direct to indirect due to transfer of shares to The Chudova Family Trust. Incorrect number of shares reported back on Form 4 dated 12/8/2025, filed 12/10/2025. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 13,097 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000006 · wk-form4_1759449869.xml · derivative · entry 7 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,592 Underlying: Common Stock · 13,097 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,668 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000006 · wk-form4_1759449869.xml · derivative · entry 6 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,669 Underlying: Common Stock · 1,668 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000006 · wk-form4_1759449869.xml · derivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,357 Underlying: Common Stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 8,163 | $62.65 | $511,411.95 |
DisclosureSEC source: 0001977179-25-000006 · wk-form4_1759449869.xml · nonDerivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,390 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 13,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000006 · wk-form4_1759449869.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000006 · wk-form4_1759449869.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000006 · wk-form4_1759449869.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 316 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000004 · wk-form4_1756939491.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 316 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares were outstanding on May 3, 2023, when the reporting person was elected as an officer. These shares vest in equal quarterly installments on the anniversary of September 1, 2022 and fully vest on September 1, 2025. F1 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 161 | $67.42 | $10,854.62 |
DisclosureSEC source: 0001977179-25-000004 · wk-form4_1756939491.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,449 F1 · shares: Not applicable for Restricted Stock Units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 316 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-25-000004 · wk-form4_1756939491.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000217 · wk-form4_1751505684.xml · derivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,337 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,340 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000217 · wk-form4_1751505684.xml · derivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,696 Underlying: Common Stock · 1,340 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,525 | $50.71 | $77,332.75 |
DisclosureSEC source: 0001576280-25-000217 · wk-form4_1751505684.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,294 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000217 · wk-form4_1751505684.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000217 · wk-form4_1751505684.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2025 Filed Jun 2, 2025 22:03 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 316 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000157 · wk-form4_1748901780.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316 Underlying: Common Stock · 316 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares were outstanding on May 3, 2023, when the reporting person was elected as an officer. These shares vest in equal quarterly installments on the anniversary of September 1, 2022 and fully vest on September 1, 2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 01, 2025 Filed Jun 2, 2025 22:03 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 161 | $40.62 | $6,539.82 |
DisclosureSEC source: 0001576280-25-000157 · wk-form4_1748901780.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,812 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 01, 2025 Filed Jun 2, 2025 22:03 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 316 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000157 · wk-form4_1748901780.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2025 Filed May 19, 2025 23:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 8,705 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000145 · wk-form4_1747696080.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,411 Underlying: Common Stock · 8,705 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on August 7, 2023 and vests over a four-year period. 25% of the shares vested on the one-year anniversary of May 15, 2023 and the remaining 75% vest annually during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| May 15, 2025 Filed May 19, 2025 23:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 4,412 | $40.46 | $178,509.52 |
DisclosureSEC source: 0001576280-25-000145 · wk-form4_1747696080.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,798 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| May 15, 2025 Filed May 19, 2025 23:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 8,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000145 · wk-form4_1747696080.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:32 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000112 · wk-form4_1743629523.xml · derivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,004 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:32 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000112 · wk-form4_1743629523.xml · derivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,036 Underlying: Common Stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vest in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:32 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,524 | $42.47 | $64,724.28 |
DisclosureSEC source: 0001576280-25-000112 · wk-form4_1743629523.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,505 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:32 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000112 · wk-form4_1743629523.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:32 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000112 · wk-form4_1743629523.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:30 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 20,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000068 · wk-form4_1741897853.xml · derivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,302 Underlying: Common Stock · 20,302 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:30 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 30,453 | $0.00 Strike: $43.10 | $0.00 |
DisclosureSEC source: 0001576280-25-000068 · wk-form4_1741897853.xml · derivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,453 Underlying: Common Stock · 30,453 shares Expires 2035-03-12 F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000052 · wk-form4_1741129732.xml · derivative · entry 6 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 632 Underlying: Common Stock · 315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares were outstanding on May 3, 2023, when the reporting person was elected as an officer. These shares vest in equal quarterly installments on the anniversary of September 1, 2022 and fully vest on September 1, 2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 5,686 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000052 · wk-form4_1741129732.xml · derivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,376 Underlying: Common Stock · 5,686 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 3,042 | $42.55 | $129,437.10 |
DisclosureSEC source: 0001576280-25-000052 · wk-form4_1741129732.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,023 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000052 · wk-form4_1741129732.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000052 · wk-form4_1741129732.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 22:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 21,863 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000036 · wk-form4_1738707284.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Not applicable for Performance-Based Restricted Stock Units. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 22:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 8,352 | $46.98 | $392,376.96 |
DisclosureSEC source: 0001576280-25-000036 · wk-form4_1738707284.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,064 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the performance-based restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 22:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 21,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000036 · wk-form4_1738707284.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000010 · wk-form4_1735945001.xml · derivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,671 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000010 · wk-form4_1735945001.xml · derivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,233 | $30.55 | $37,668.15 |
DisclosureSEC source: 0001576280-25-000010 · wk-form4_1735945001.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,553 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000010 · wk-form4_1735945001.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000010 · wk-form4_1735945001.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 00:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 316 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000291 · wk-form4_1733185293.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 947 Underlying: Common Stock · 316 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares were outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and will fully vest on 9/1/2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 00:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 161 | $35.61 | $5,733.21 |
DisclosureSEC source: 0001576280-24-000291 · wk-form4_1733185293.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,780 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 00:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 316 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000291 · wk-form4_1733185293.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:09 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 39,689 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000267 · wk-form4_1731452945.xml · derivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,689 Underlying: Common Stock · 39,689 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:09 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 59,534 | $0.00 Strike: $28.61 | $0.00 |
DisclosureSEC source: 0001576280-24-000267 · wk-form4_1731452945.xml · derivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,534 Underlying: Common Stock · 59,534 shares Expires 2034-11-08 F1 · derivative.exercise_date: This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.